Robert McBane, M.D. – FDA 483, Jun 23, 2021
An FDA inspection of Robert D. McBane, M.D., Clinical Investigator, revealed significant non-compliance with investigational plans and regulatory requirements. The firm failed to properly report numerous adverse and serious adverse events, ensure subjects received informed consent forms, and provide adequate oversight of study tasks, including eligibility assessments and delegation of authority. These deficiencies indicate a systemic failure to conduct clinical investigations in accordance with established protocols and commitments.
ID · ceb7f976-3dae-404d-84e9-b44e96b0d4a0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.